Log In
BCIQ
Print this Print this
 

anti-CCHF

  Manage Alerts
Collapse Summary General Information
Company Fab'entech
DescriptionPolyclonal immunoglobulin fragments against Crimean-Congo hemorrhagic fever virus
Molecular Target
Mechanism of ActionImmunotherapy; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationViral hemorrhagic fever
Indication DetailsTreat Crimean-Congo hemorrhagic fever
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today